microdose glp 1 menopause GLP-1 Agonists in Perimenopause: Unique Risks and Potential Opportunities Noom Launches Microdose GLP-1 Program,

The brand's FAQ separately references head-to-head clinical-trial context comparing tirzepatide and semaglutide, but this article does not treat those studies as clinical validation of Telos Rx's own compounded formulations

Ans: No, there are no artificial flavors or preservatives in this formula

Whether that balance holds across doses, populations, and long durations is precisely what the clinical program is designed to test and why the glucagon arm is described as the differentiator and the risk

Scafidi S, et al

Measurement of peritoneal fluids for the inflammatory cytokine TNF and its soluble inhibitor sTNFR1 also showed no differences in their levels with diet (Table 1)